What one share of Surrozen, Inc./DE holds
We are a biotechnology company committed to discovering and developing product candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair. Our current strategic focus is ophthalmology, where Wnt signaling plays a central role in retinal vascular integrity, barrier function, and tissue maintenance.
Surrozen, Inc./DE’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.14 |
|---|---|
| Profit | −$33.02 |
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$3.48 |
| Cash and investments | $8.68 |
| Book value | −$18.60 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | — | −$30.72 | $0.82 | −$28.15 | — | $38.86 |
| 2021 | $0.00 | −$33.20 | $0.77 | −$30.43 | — | $46.97 |
| 2022 | $5.40 | −$15.56 | $0.31 | −$19.39 | — | $37.89 |
| 2023 | $0.00 | −$21.33 | $0.20 | −$20.20 | — | $18.39 |
| 2024 | $3.63 | −$21.67 | $0.01 | −$6.02 | — | −$6.55 |
| 2025 | $0.47 | −$32.37 | $0.02 | −$4.06 | — | −$19.21 |
Common questions about Surrozen, Inc./DE
How much does one share of Surrozen, Inc./DE earn?
Over the last 12 months, Surrozen, Inc./DE lost $33.02 for each share on $1.14 of sales.
Does Surrozen, Inc./DE pay a dividend?
Surrozen, Inc./DE didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Surrozen, Inc./DE’s book value per share?
Surrozen, Inc./DE’s book value is negative (−$18.60 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Surrozen, Inc./DE have?
Each share of Surrozen, Inc./DE has $8.68 of cash and investments, as of June 30, 2026.
What is Surrozen, Inc./DE’s free cash flow per share?
−$3.48 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Surrozen, Inc./DE bought back shares?
Surrozen, Inc./DE’s share count rose about 602% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.